Jad Othman

27PUBLICATIONS

164CO-AUTHORS

Gene and molecular therapyMedical virologyGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursMedical mycology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (27)

Sort by Publication Date:

|Jul 02, 2026

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

|Jun 04, 2026

ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid Leukemia.

|Apr 28, 2026

Finding the genes that fit CPX-351.

|Apr 13, 2026

Elevated levels of TNF and its targets characterize better-risk older acute myeloid leukemia patients.

Yaseswini Neelamraju, Franck Rapaport, Jorge A Gandara

|Dec 15, 2025

2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

|Sep 30, 2025

Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.

Nigel Russell, Jad Othman, Oliver Cumming

Pageof 5

Frequent Collaborators

10 joint publications

Richard Dillon

Nicola Potter

Sylvie D Freeman

Ing Soo Tiong

Andrew H Wei

Joanna Canham

Steven Knapper

Sun Loo

Sean Johnson

Christian Thiede

Frequent Collaborators

10 joint publications

Richard Dillon

9 joint publications

Nicola Potter

8 joint publications

Sylvie D Freeman

6 joint publications

Ing Soo Tiong